Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

The multiple actions of testosterone in men: nature knows best.

Funder JW.

Asian J Androl. 2014 Mar-Apr;16(2):266-7. doi: 10.4103/1008-682X.122367.

2.

Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.

Juang PS, Peng S, Allehmazedeh K, Shah A, Coviello AD, Herbst KL.

J Sex Med. 2014 Feb;11(2):563-73. doi: 10.1111/jsm.12368. Epub 2013 Nov 6.

PMID:
24344872
3.

Effects of a purported aromatase and 5α-reductase inhibitor on hormone profiles in college-age men.

Wilborn C, Taylor L, Poole C, Foster C, Willoughby D, Kreider R.

Int J Sport Nutr Exerc Metab. 2010 Dec;20(6):457-65.

PMID:
21116018
4.

Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.

Idan A, Griffiths KA, Harwood DT, Seibel MJ, Turner L, Conway AJ, Handelsman DJ.

Ann Intern Med. 2010 Nov 16;153(10):621-32. doi: 10.7326/0003-4819-153-10-201011160-00004.

PMID:
21079217
5.

The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men.

Lakshman KM, Kaplan B, Travison TG, Basaria S, Knapp PE, Singh AB, LaValley MP, Mazer NA, Bhasin S.

J Clin Endocrinol Metab. 2010 Aug;95(8):3955-64. doi: 10.1210/jc.2010-0102. Epub 2010 Jun 9.

6.

Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals.

Meriggiola MC, Armillotta F, Costantino A, Altieri P, Saad F, Kalhorn T, Perrone AM, Ghi T, Pelusi C, Pelusi G.

J Sex Med. 2008 Oct;5(10):2442-53. doi: 10.1111/j.1743-6109.2008.00909.x. Epub 2008 Jul 1.

PMID:
18624972
7.

Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial.

Hawkins VN, Foster-Schubert K, Chubak J, Sorensen B, Ulrich CM, Stancyzk FZ, Plymate S, Stanford J, White E, Potter JD, McTiernan A.

Med Sci Sports Exerc. 2008 Feb;40(2):223-33. doi: 10.1249/mss.0b013e31815bbba9.

8.

Postnatal testosterone exposure results in insulin resistance, enlarged mesenteric adipocytes, and an atherogenic lipid profile in adult female rats: comparisons with estradiol and dihydrotestosterone.

Alexanderson C, Eriksson E, Stener-Victorin E, Lystig T, Gabrielsson B, Lönn M, Holmäng A.

Endocrinology. 2007 Nov;148(11):5369-76. Epub 2007 Jul 26.

PMID:
17656458
9.

Dihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice.

Movérare-Skrtic S, Venken K, Andersson N, Lindberg MK, Svensson J, Swanson C, Vanderschueren D, Oscarsson J, Gustafsson JA, Ohlsson C.

Obesity (Silver Spring). 2006 Apr;14(4):662-72.

10.

Pubertal androgen therapy in boys.

Rogol AD.

Pediatr Endocrinol Rev. 2005 Mar;2(3):383-90. Review.

PMID:
16429115
11.

Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects.

Borst SE, Lee JH, Conover CF.

Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E222-7. Epub 2004 Sep 14.

12.

Effects of androgenic-anabolic steroids in athletes.

Hartgens F, Kuipers H.

Sports Med. 2004;34(8):513-54. Review.

PMID:
15248788
13.

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS.

J Clin Endocrinol Metab. 2004 May;89(5):2085-98.

PMID:
15126525
14.

Testosterone action on skeletal muscle.

Herbst KL, Bhasin S.

Curr Opin Clin Nutr Metab Care. 2004 May;7(3):271-7. Review.

PMID:
15075918
15.

Plasma lipoprotein profile in the male cynomolgus monkey under normal, hypogonadal, and combined androgen blockade conditions.

Leblanc M, Bélanger MC, Julien P, Tchernof A, Labrie C, Bélanger A, Labrie F.

J Clin Endocrinol Metab. 2004 Apr;89(4):1849-57.

PMID:
15070955
16.

Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.

Vandenput L, Boonen S, Van Herck E, Swinnen JV, Bouillon R, Vanderschueren D.

J Bone Miner Res. 2002 Nov;17(11):2080-6.

17.

The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model.

Vandenput L, Swinnen JV, Van Herck E, Verstuyf A, Boonen S, Bouillon R, Vanderschueren D.

Calcif Tissue Int. 2002 Mar;70(3):170-5. Epub 2002 Jan 28.

PMID:
11907714
18.

Dihydrotestosterone treatment in adolescents with delayed puberty: does it explain insulin resistance of puberty?

Saad RJ, Keenan BS, Danadian K, Lewy VD, Arslanian SA.

J Clin Endocrinol Metab. 2001 Oct;86(10):4881-6.

PMID:
11600557
19.
20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk